Neochem Bio Solutions Ltd (NEOCHEM) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Sales | 48.19 | 61.15 | 84.17 |
| Expenses | 43.95 | 55.16 | 71.05 |
| Operating Profit | 4.24 | 5.99 | 13.12 |
| OPM | 8.8% | 9.8% | 15.59% |
| Other Income | 0.6 | 0.86 | 1.98 |
| Interest | 2.1 | 2.96 | 3.51 |
| Depreciation | 1.22 | 1.22 | 1.33 |
| Profit before tax | 1.52 | 2.67 | 10.26 |
| Tax | 28.95% | 32.58% | 24.46% |
| Net Profit | 1.07 | 1.8 | 7.75 |
| EPS in Rs | 1.13 | 1.54 | 6.62 |
| Dividend Payout | 0% | 0% | 0% |
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Equity Capital | 5.43 | 6.68 | 6.68 |
| Reserves | 2.63 | 5.33 | 13.08 |
| Borrowings | 26.24 | 33.32 | 35.63 |
| Other Liabilities | 16.31 | 18.73 | 23.5 |
| Total Liabilities | 50.61 | 64.06 | 78.89 |
| Fixed Assets | 14.67 | 18.81 | 18.67 |
| CWIP | 0.04 | 0.03 | 0.06 |
| Investments | 0 | 0 | 0 |
| Other Assets | 35.9 | 45.22 | 60.16 |
| Total Assets | 50.61 | 64.06 | 78.89 |
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Cash from Operating Activity | -0.74 | 1.96 | 2.59 |
| Cash from Investing Activity | -3.35 | -7.86 | -1.69 |
| Cash from Financing Activity | 3.76 | 6.2 | -1.2 |
| Net Cash Flow | -0.34 | 0.3 | -0.3 |
| Free Cash Flow | -4.07 | -3.37 | 1.45 |
| CFO/OP | -11% | 40% | 26% |
| CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit | -11 | 40 | 26 |
| Metric | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Debtor Days | 109.22 | 102.9 | 109.63 |
| Inventory Days | 174.77 | 172.24 | 157.02 |
| Days Payable | 156.98 | 133.36 | 107.72 |
| Cash Conversion Cycle | 127.01 | 141.78 | 158.93 |
| Working Capital Days | 20.53 | 32.29 | 39.33 |
| ROCE | - | 14.09% | 27.2% |